Development or Exacerbation of Head and Neck Dermatitis in Patients Treated for Atopic Dermatitis With Dupilumab

JAMA Dermatol. 2019 Sep 4;155(11):1312-1315. doi: 10.1001/jamadermatol.2019.2613. Online ahead of print.

Abstract

This cohort study describes the development or exacerbation of head and neck dermatitis in patients treated with dupilumab for atopic dermatitis.